Resverlogix Corp. (TSE:RVX – Get Free Report)’s stock price passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of C$0.10 and traded as low as C$0.10. Resverlogix shares last traded at C$0.11, with a volume of 11,020 shares changing hands.
Resverlogix Trading Up 5.0%
The stock has a market cap of C$30.08 million, a PE ratio of -2.63 and a beta of 0.78. The company has a quick ratio of 0.04, a current ratio of 0.13 and a debt-to-equity ratio of -10.95. The stock’s fifty day moving average price is C$0.10 and its 200 day moving average price is C$0.08.
Resverlogix Company Profile
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Featured Stories
- Five stocks we like better than Resverlogix
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- onsemi Places a $6 Billion Bet on Its Own Stock
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- HIMS Has Been a Roller Coaster Ride. Should Investors Hop On?
- Best Stocks Under $5.00
- End the Year Strong With These 3 Comeback Champions
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
